5 completed, 2 recruiting, 1 terminated. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 5, Recruiting 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Gambling: new trials by email Literature Review of Gambling trials Research Report on Gambling
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions Nalmefene, Placebo - Behavioural Addiction | Phase 3 | Recruiting | Nantes University Hospital | 266 | 2023-03-31 | 2025-02-12 |
| Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation Transcranial Magnetic stimulation - Gambling Disorder | Phase 3 | Recruiting | CNS Onlus | 40 | 2018-05-20 | 2018-09-13 |
| The Effect of Transcranial Direct Current Stimulation on Decision Making and Cognitive Flexibility in Gambling Disorder Transcranial direct current stimulation - Gambling Disorder | Phase 3 | Completed | Istanbul University | 20 | 2017-03-29 | 2018-03-26 |
| Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling olanzapine, sugar pill - Pathological Gambling | Phase 3 | Completed | Lindner Center of HOPE | 42 | 2007-02-01 | 2011-12-13 |
| Topiramate in the Treatment of Pathological Gambling Topiramate, Placebo - Pathological Gambling | Phase 3 | Terminated | Icahn School of Medicine at Mount Sinai | 42 | 2005-10-01 | 2019-07-02 |
| Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling nalmefene HCl, Placebo - Pathological Gambling | Phase 2 / Phase 3 | Completed | Somaxon Pharmaceuticals | 233 | 2005-08-01 | 2008-05-19 |
| Minimal and Brief Treatments for Pathological Gamblers Self-help treatment - Pathological Gambling | Phase 3 | Completed | University of Calgary | 312 | 2003-07-01 | 2009-02-16 |
| Drug Treatment for Pathologic Gambling Disorder Naltrexone, Placebo - Gambling | Phase 3 | Completed | University of Chicago | 83 | 2002-12-01 | 2023-02-23 |
Compulsive Sexual Behavior Disorder (1) · Disruptive, Impulse Control, and Conduct Disorders (1) · Food Addiction (1)
Behavior (8) · Mental Disorders (8) · Risk-Taking (8) · Disruptive, Impulse Control, and Conduct Disorders (7) · Behavior, Addictive (1) · Compulsive Behavior (1) · Feeding and Eating Disorders (1) · Impulsive Behavior (1) · Sexual Dysfunctions, Psychological (1) · Sexual and Gender Disorders (1)
nalmefene (2) · Bibliotherapy (1) · Motivational Interviewing (1) · Naltrexone (1) · Olanzapine (1) · Sugars (1) · Topiramate (1) · Transcranial Direct Current Stimulation (1) · Transcranial Magnetic Stimulation (1)
CNS Onlus (1) · Icahn School of Medicine at Mount Sinai (1) · Istanbul University (1) · Lindner Center of HOPE (1) · Nantes University Hospital (1) · Somaxon Pharmaceuticals (1) · University of Calgary (1) · University of Chicago (1)
United States (3) · Canada (1) · France (1) · Italy (1) · Turkey (Türkiye) (1)
Ahmet Z Soyata (1) · David C Hodgins, PhD. (1) · Eric Hollander, MD (1) · Philip Jochelson, MD (1) · Suck Won Kim, M.D. (1) · Susan L McElroy, MD (1)
PMID 18251624, PMID 21486110, PMID 30367243, PMID 42004899
R21MH065920 (1)